Literature DB >> 2825416

A comparison of six different bluetongue virus isolates by cross-hybridization of the dsRNA genome segments.

P P Mertens1, S Pedley, J Cowley, J N Burroughs.   

Abstract

The relationship between six different isolates of BTV was analyzed by cross-hybridization of genomic dsRNA using blotting and probe techniques (using an alkali fragmented probe made from BTV dsRNA). The viruses compared in this way included BTV serotype 1 from South Africa, serotypes 3 and 4 from Cyprus, serotype 10 from North America, and serotypes 1 and 20 from Australia. Under the hybridization and washing conditions used, which were calculated to allow stable duplex formation between RNA molecules containing greater than 90% sequence homology, two of the genome segments (segments 2 and either 5 or 6, which encode the two major outer capsid proteins VP2 and VP5) appeared to contain serotype-specific RNA sequences. Significant cross-hybridization between these segments from different serotypes was detected only with serotypes 4 and 20, which are known to have a particularly close antigenic relationship. The amounts of homologous sequence that were detected in segments other than 2 and 5 between different viruses indicated some correlation between their geographical origins and a degree of relatedness, which is independent of the virus serotype. High levels of sequence homology were detected between the isolates from Cyprus and Africa and to a slightly lesser extent from North America, suggesting a common ancestry. These results also indicated that within the limited number of viruses studied, the Australian isolates form a separate interrelated group of bluetongue viruses.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2825416     DOI: 10.1016/0042-6822(87)90137-1

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  8 in total

1.  The core of bluetongue virus binds double-stranded RNA.

Authors:  J M Diprose; J M Grimes; G C Sutton; J N Burroughs; A Meyer; S Maan; P P C Mertens; D I Stuart
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

2.  Full genome sequence of bluetongue virus serotype 4 from China.

Authors:  Heng Yang; Jianbo Zhu; Huachun Li; Lei Xiao; Jinpin Wang; Nan Li; Nianzu Zhang; Peter D Kirkland
Journal:  J Virol       Date:  2012-12       Impact factor: 5.103

3.  Complete genomic sequence of bluetongue virus serotype 1 from China.

Authors:  Tao Yang; Nihong Liu; Qingyuan Xu; Encheng Sun; Yongli Qin; Jing Zhao; Yufei Feng; Donglai Wu
Journal:  J Virol       Date:  2012-01       Impact factor: 5.103

4.  Complete genomic sequence of bluetongue virus serotype 16 from China.

Authors:  Tao Yang; Nihong Liu; Qingyuan Xu; Encheng Sun; Yongli Qin; Jin Zhao; Donglai Wu
Journal:  J Virol       Date:  2011-12       Impact factor: 5.103

5.  Complete genome sequence of bluetongue virus serotype 16 of goat origin from India.

Authors:  Prasad Minakshi; Ravinder Singh; Koushlesh Ranjan; Pawan Kumar; Chaitanya G Joshi; Y Krishna Mohan Reddy; Gaya Prasad
Journal:  J Virol       Date:  2012-08       Impact factor: 5.103

6.  Full genome characterisation of bluetongue virus serotype 6 from the Netherlands 2008 and comparison to other field and vaccine strains.

Authors:  Sushila Maan; Narender S Maan; Piet A van Rijn; René G P van Gennip; Anna Sanders; Isabel M Wright; Carrie Batten; Bernd Hoffmann; Michael Eschbaumer; Chris A L Oura; Abraham C Potgieter; Kyriaki Nomikou; Peter P C Mertens
Journal:  PLoS One       Date:  2010-04-23       Impact factor: 3.240

7.  Genetic modification of Bluetongue virus by uptake of "synthetic" genome segments.

Authors:  René G P van Gennip; Daniel Veldman; Sandra G P van de Water; Piet A van Rijn
Journal:  Virol J       Date:  2010-10-07       Impact factor: 4.099

8.  Identification and differentiation of the twenty six bluetongue virus serotypes by RT-PCR amplification of the serotype-specific genome segment 2.

Authors:  Narender S Maan; Sushila Maan; Manjunatha N Belaganahalli; Eileen N Ostlund; Donna J Johnson; Kyriaki Nomikou; Peter P C Mertens
Journal:  PLoS One       Date:  2012-02-28       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.